Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 5
2011 1
2012 2
2013 1
2014 1
2015 2
2016 1
2017 1
2018 2
2019 3
2020 1
2021 1
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Proportion and characteristics of secondary progressive multiple sclerosis in five European registries using objective classifiers.
Forsberg L, Spelman T, Klyve P, Manouchehrinia A, Ramanujam R, Mouresan E, Drahota J, Horakova D, Joensen H, Pontieri L, Magyari M, Ellenberger D, Stahmann A, Rodgers J, Witts J, Middleton R, Nicholas R, Bezlyak V, Adlard N, Hach T, Lines C, Vukusic S, Soilu-Hänninen M, van der Walt A, Butzkueven H, Iaffaldano P, Trojano M, Glaser A, Hillert J; SPMS Research Collaboration Network. Forsberg L, et al. Among authors: bezlyak v. Mult Scler J Exp Transl Clin. 2023 Feb 16;9(1):20552173231153557. doi: 10.1177/20552173231153557. eCollection 2023 Jan-Mar. Mult Scler J Exp Transl Clin. 2023. PMID: 36816812 Free PMC article.
How do patients with secondary progressive multiple sclerosis enrolled in the EXPAND randomized controlled trial compare with those seen in German clinical practice in the NeuroTransData multiple sclerosis registry?
Braune S, Bergmann A, Bezlyak V, Adlard N. Braune S, et al. Among authors: bezlyak v. J Cent Nerv Syst Dis. 2022 Aug 4;14:11795735221115912. doi: 10.1177/11795735221115912. eCollection 2022. J Cent Nerv Syst Dis. 2022. PMID: 35958354 Free PMC article.
The impact of healthcare systems on the clinical diagnosis and disease-modifying treatment usage in relapse-onset multiple sclerosis: a real-world perspective in five registries across Europe.
Nicholas R, Rodgers J, Witts J, Lerede A, Friede T, Hillert J, Forsberg L, Glaser A, Manouchehrinia A, Ramanujam R, Spelman T, Klyve P, Drahota J, Horakova D, Joensen H, Pontieri L, Magyari M, Ellenberger D, Stahmann A, Butzkueven H, Van Der Walt A, Bezlyak V, Lines C, Middleton R. Nicholas R, et al. Among authors: bezlyak v. Ther Adv Neurol Disord. 2023 Sep 26;16:17562864231198963. doi: 10.1177/17562864231198963. eCollection 2023. Ther Adv Neurol Disord. 2023. PMID: 37771841 Free PMC article.
Ranibizumab 0.5 mg treat-and-extend regimen for diabetic macular oedema: the RETAIN study.
Prünte C, Fajnkuchen F, Mahmood S, Ricci F, Hatz K, Studnička J, Bezlyak V, Parikh S, Stubbings WJ, Wenzel A, Figueira J; RETAIN Study Group. Prünte C, et al. Among authors: bezlyak v. Br J Ophthalmol. 2016 Jun;100(6):787-95. doi: 10.1136/bjophthalmol-2015-307249. Epub 2015 Oct 9. Br J Ophthalmol. 2016. PMID: 26453639 Free PMC article. Clinical Trial.
22 results